Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Үндсэн зохиолчид: | Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, Johan Wardell, Nils Witt, Yang Cao, Leif Bojö, Bo Nilsson, Johan Jendle |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Frontiers Media S.A.
2018-02-01
|
Цуврал: | Frontiers in Endocrinology |
Нөхцлүүд: | |
Онлайн хандалт: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00050/full |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
-н: Thomas Nyström, зэрэг
Хэвлэсэн: (2017-11-01) -
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
-н: J. Jendle, зэрэг
Хэвлэсэн: (2021-12-01) -
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
-н: Nikolai N. Scherbak, зэрэг
Хэвлэсэн: (2023-09-01) -
Liraglutide overdose: A case report and an updated review
-н: Sharafaldeen Bin Nafisah, зэрэг
Хэвлэсэн: (2020-01-01) -
Metformin exerts synergistic anti-proliferative effects with Liraglutide in human umbilical vein endothelial cells (HUVECs)
-н: Amir Shadboorestan, зэрэг
Хэвлэсэн: (2022-04-01)